UEMS Medical Specialty
Gastroenterology
Precision microbiome interventions, short-chain fatty acid (SCFA) delivery, enteric coating technologies, and gut–brain axis modulation for gastrointestinal and liver health.
28
dossiers
Post-GLP-1 Metabolic Optimization
Evidence-Based Dietary Patterns, Ultra-Processed Foods, and Sodium-Potassium Balance: 2025-2026 Insights
Translating nuanced dietary evidence regarding food processing, quality, and electrolyte balance into convenient, effective, and compliant nutritional products for specific patient populations is a complex CDMO challenge. Ensuring palatability and long-term adherence to these precise formulations adds further difficulty.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Medical Foods and Foods for Special Medical Purposes: Regulatory Frameworks and Clinical Nutrition Across Key Regions
Navigating the complex and divergent regulatory frameworks for medical foods in the US and FSMPs in the EU/GCC makes consistent product development, labelling, and market access a significant hurdle for specialized clinical nutrition.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Foods for Special Medical Purposes in Oncology: Nutrition Support & Oral Mucositis Adjunct
Developing clinically substantiated Foods for Special Medical Purposes (FSMPs) and medical foods for cancer patients is challenging due to diverse nutritional needs, metabolic derangements, and specific treatment toxicities like oral mucositis, requiring regulatory diligence and demonstrated efficacy.
Microvascular Hemodynamics & Endothelial Integrity
Erythritol and Human Health, 2020–2026: A PRISMA-Style Systematic Evidence Synthesis
Formulators face the critical challenge of ensuring product safety and consumer trust when using erythritol, given emerging data on its acute cardiovascular effects and potential long-term risks, especially at high intake levels common in ketogenic or diabetic products.
Intracellular Defense & IV-Alternatives
Integrated Metabolic Pathways for Immune Support, Fatigue Reduction, and Cellular Protection: A Mechanistic Review
Designing effective nutritional or pharmaco-nutritional interventions is challenging given the complex, interconnected nature of metabolic pathways supporting immunity, energy, and cellular protection. Delivering pleiotropic compounds efficiently to multiple intracellular targets without systemic burden is critical.
Precision Microbiome & Gut-Brain Axis
Enteric-Targeted Butyrate Delivery for Vagal Nerve Stimulation: Addressing Gastric Degradation and Organoleptic Challenges
Designing oral butyrate formulations is challenged by premature gastric dissolution, proximal absorption, and severe organoleptic issues, preventing effective distal gut targeting and patient adherence.
Glycolysis-Restricted FSMP (Oncology Nutrition)
The Glucose Paradox in Oncology Nutrition: High-Glycemic Medical Foods and Cancer Outcomes
Current sugar-dominant oncology medical foods may inadvertently fuel tumor growth and worsen metabolic dysfunction in cancer patients. Developing nutritionally complete, low-glycemic formulations that support anabolism without pro-oncogenic effects is a critical challenge.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Interventions in Neurodegeneration: Mechanisms, Clinical Efficacy, and Therapeutic Challenges
Developing clinically robust and compliant ketogenic interventions for neurodegenerative diseases requires overcoming challenges related to variable metabolic responses, sustained therapeutic ketosis, and precise delivery of ketone bodies or precursors in diverse patient populations.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Food Supplements and Medical Foods in Brain Function: A Mechanism-Anchored Evidence Map
Formulators face significant challenges in developing evidence-based brain health supplements due to a lack of clear, mechanism-anchored frameworks for evaluating ingredient efficacy and quality of supporting human data across diverse brain function domains.
Precision Microbiome & Gut-Brain Axis
Norovirus: Virology, Epidemiology, Clinical Disease, Prevention, and Treatment Review
Developing effective norovirus vaccines and direct-acting antivirals is challenged by viral genetic diversity, genotype-specific host tropism, and the absence of a definitive cellular receptor. Current supportive care highlights an urgent need for targeted interventions.
Precision Microbiome & Gut-Brain Axis
Rheumatoid Arthritis and Mental Health: Psychoneuroimmunological Links and Therapeutic Implications
The primary challenge is to develop targeted therapeutic and nutritional interventions that modulate inflammatory pathways and the HPA axis to improve mental health outcomes in patients suffering from chronic autoimmune conditions like rheumatoid arthritis.
Microvascular Hemodynamics & Endothelial Integrity
Edestin's Health Benefits: Mechanistic Domains and Phlebology Applications
The primary challenge involves translating edestin's mechanistic benefits (antihypertensive, antioxidant, anti-inflammatory, endothelial effects) into proven clinical outcomes for phlebology, given current evidence gaps in venous disease trials. Optimizing processing and peptide delivery for enhanced bioavailability and targeted action in vascular health is critical.
Post-GLP-1 Metabolic Optimization
Drug-Induced Nutrient Depletion (DIND): Molecular Mechanisms of Iatrogenic Deficiencies in Chronic Pharmacotherapy
Mitigating drug-induced nutrient depletion requires advanced CDMO solutions to formulate targeted nutritional support that is compatible with existing chronic pharmacotherapy and addresses diverse mechanistic pathways of depletion.
Precision Microbiome & Gut-Brain Axis
Hidden Pharmacodynamics of Pharmaceutical Formulations: Excipient, Impurity, and Oxidation Index Impact on Clinical Safety
Pharmaceutical and nutraceutical formulations often overlook the direct pharmacodynamic effects of excipients and the toxicity of oxidation byproducts, risking unforeseen clinical safety issues that extend beyond the API's profile.
Post-GLP-1 Metabolic Optimization
Amino-Peptide Matrices for Lean Mass Preservation in GLP-1 Receptor Agonist-Induced Gastroparesis
GLP-1 RA-induced gastroparesis and retained gastric contents present a significant challenge for effective oral nutrition delivery and lean mass preservation during weight loss therapy, especially in at-risk populations.
Precision Microbiome & Gut-Brain Axis
Gut-Brain Axis and Mental Illness: Microbiota, Mechanisms, and Testable Hypotheses
Translating complex gut-brain axis insights into effective, targeted formulations for psychiatric conditions requires addressing variable microbiome signatures, diverse mechanistic pathways, and inconsistent clinical trial outcomes.
Precision Microbiome & Gut-Brain Axis
The Neuroimmune Continuum: Mechanisms, Paradigm Shifts, and Translational Frontiers in Psychoneuroimmunology
Translating complex psychoneuroimmunological mechanisms, including BBB permeability, specific cytokine pathways, and targeted microglial modulation, into stable and bioavailable therapeutic formulations presents a significant CDMO hurdle.
Transmucosal Delivery & Dosage Form Engineering
Nutraceutical Pharmacokinetics: Advanced Delivery Systems for Improved Bioavailability
Many clinically relevant nutraceuticals exhibit poor oral bioavailability due to extensive first-pass metabolism and unfavorable physicochemical properties, making their therapeutic efficacy unpredictable in conventional forms.
Transmucosal Delivery & Dosage Form Engineering
Breakthroughs in Nutraceutical & Functional Food Technology: Delivery Systems, Green Manufacturing, and AI-Driven Precision Nutrition
Developing advanced nutraceuticals is challenged by low ingredient solubility, poor stability, and the lack of targeted or controlled release mechanisms, hindering optimal bioavailability and physiological efficacy. Ensuring robust evidence and regulatory acceptance for novel formulations further complicates development.
Precision Microbiome & Gut-Brain Axis
Pharmacomicrobiomics: Gut Microbiota Modulation of Drug Efficacy and Nutraceutical Biotransformation
Integrating the profound and variable metabolic capacity of the gut microbiome into pharmaceutical development to ensure consistent drug efficacy and bioavailability across diverse patient populations is a significant hurdle.
Transmucosal Delivery & Dosage Form Engineering
Piperine-Mediated Potentiation of Direct Oral Anticoagulants: A Clinically Unrecognized Hemorrhagic Risk
Piperine, marketed as a 'bio-enhancer' in nutraceuticals, dangerously potentiates DOACs by inhibiting P-gp and CYP3A4, leading to critical hemorrhagic risk due to uncontrolled increases in drug exposure. This unrecognized interaction demands safer alternatives for enhancing polyphenol bioavailability.
Post-GLP-1 Metabolic Optimization
Triple Agonists and Next-Generation Oral GLP-1s: Advancements in Metabolic Disorder Therapeutics
Formulating complex multi-receptor agonists and high-potency oral GLP-1 peptides requires advanced delivery systems to ensure bioavailability, stability, and patient adherence while mitigating gastrointestinal side effects.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Diet-Specified Interventions in Neurodegenerative Disease Mechanisms
Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.
Precision Microbiome & Gut-Brain Axis
Nutrition and Psychiatric Disorders: A Comprehensive Narrative Review of the Evidence Through 2026
Optimal dietary interventions for psychiatric disorders remain poorly standardized and show high variability in effectiveness.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.